Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities    
Net loss $ (3,146) $ (1,740)
Adjustments to reconcile net loss to net cash used in operating activities:    
Realized loss on marketable debt securities 12 130
Loss on discontinued operations, net of taxes 40 170
Depreciation and amortization 398 383
Stock-based compensation expense 744 634
Changes in operating assets and liabilities:    
Accounts receivable 936 (1,023)
Inventory 444 (372)
Prepaid and other assets (8) 185
Accounts payable and accrued expenses (14) (125)
Accrued advertising and other allowances (99)
Due to Mylan, Inc. and affiliates (59)
Other liabilities (247) (225)
Assets held for sale 22
Net cash used in operating activities (841) (2,119)
Cash flows from investing activities    
Purchase of marketable securities (3,137) (13,350)
Proceeds from maturities of marketable debt securities 14,280
Proceeds from sale of marketable debt securities 8,908 11,071
Capital expenditures (228) (140)
Net cash provided by investing activities 5,543 11,862
Cash flows from financing activities    
Payment of dividends (5,822) (11,700)
Proceeds from exercise of stock options 337
Net cash used in financing activities (5,822) (11,362)
Decrease in cash and cash equivalents (1,120) (1,619)
Cash and cash equivalents, at the beginning of the year 1,554 3,173
Cash and cash equivalents, at the end of the year 434 1,554
Supplemental disclosures:    
Cash paid for income taxes 103
Supplemental disclosure of non-cash investing and financing activities:    
Net unrealized gain, investments in marketable debt securities $ 22 $ 54